Simplex Trading’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-500
Closed -$4K 8438
2025
Q3
$4K Buy
+500
New +$4.78K ﹤0.01% 8371
2024
Q1
Sell
-2,000
Closed -$45K 8775
2023
Q4
$45K Hold
2,000
﹤0.01% 6168
2023
Q3
$37K Buy
2,000
+1,100
+122% +$22.8K ﹤0.01% 6064
2023
Q2
$23K Buy
+900
New +$24.1K ﹤0.01% 6615
2022
Q2
Sell
-400
Closed -$10K 9870
2022
Q1
$10K Buy
+400
New +$12.2K ﹤0.01% 8842
2021
Q2
Sell
-26
Closed -$106K 9967
2021
Q1
$106K Buy
26
+21
+420% +$797 ﹤0.01% 5662
2020
Q4
$22K Buy
+5
New +$190 ﹤0.01% 6899
2020
Q1
Sell
-89
Closed -$461K 7532
2019
Q4
$461K Sell
89
-4
-4% -$232 ﹤0.01% 2828
2019
Q3
$510K Buy
+93
New +$4.78K ﹤0.01% 2601
2019
Q2
Sell
-72
Closed -$217K 7033
2019
Q1
$217K Buy
72
+35
+95% +$1.2K ﹤0.01% 3520
2018
Q4
$124K Buy
37
+27
+270% +$975 ﹤0.01% 3634
2018
Q3
$42K Buy
10
+9
+900% +$356 ﹤0.01% 5328
2018
Q2
$3K Sell
1
-39
-98% -$1.61K ﹤0.01% 6883
2018
Q1
$5K Buy
+40
New +$2.26K ﹤0.01% 4584
2017
Q4
Sell
-22
Closed -$9K 5924
2017
Q3
$9K Buy
+22
New +$1.15K ﹤0.01% 3832
2016
Q4
Sell
-76
Closed -$11K 5775
2016
Q3
$11K Buy
+76
New +$3.75K ﹤0.01% 3506
2015
Q4
Sell
-30
Closed -$3K 5330
2015
Q3
$3K Buy
30
+14
+88% +$488 ﹤0.01% 4314
2015
Q2
$4K Buy
16
+6
+60% +$214 ﹤0.01% 3771
2015
Q1
$1K Buy
+10
New +$404 ﹤0.01% 4375

Other funds holding ANIK

Simplex Trading's ANIK Position: Q2 2026 in Review

Simplex Trading sold out of Anika Therapeutics (ANIK) in Q2 2026, closing a stake of 70 shares — an estimated $1.01K sold.

Simplex Trading first reported a position in ANIK in Q4 2014 and held it in 24 quarters. The position peaked at $343K in Q3 2017. 134 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • Simplex Trading reported no remaining Anika Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 70 Anika Therapeutics shares in Q2 2026, an estimated $1.01K.
  • Simplex Trading first reported a position in Anika Therapeutics in Q4 2014 and held it in 24 quarters.
  • Simplex Trading's Anika Therapeutics position peaked at $343K in Q3 2017.
  • 134 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.